D1 dopamine receptors, schizophrenia, and antipsychotic medications

Neurotransmitter Receptors in Actions of Antipsychotic Medications

Volumn , Issue , 2000, Pages 65-78

  Kurumaji, Akeo ^a   Okubo, Yoshiro ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0003005126     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (87)

1. Seeman, P., Dopamine receptor: clinical correlate, in Psychopharmacology: The Fourth Generation of Progress, Bloom, F.E. and Kupfer, D.J., Eds., Raven Press, Ltd., New York, 1995, chap. 26.
2. Seeman, P. and Niznik, H.B., Dopamine receptors and transporters in Parkinson’s disease and schizophrenia, FASEB J., 4, 2737, 1990.
3. Weinberger, D.R., Implications of normal brain development for the pathogenesis of schizophrenia, Arch. Gen. Psychiatry, 44, 660, 1987.
4. Weinberger, D.R., Schizophrenia and the frontal lobe, Trends Neurosci., 11, 367, 1988.
5. Goldman, R.P., Working memory dysfunction in schizophrenia, J. Neuropsychiatry Clin. Neurosci., 6, 348, 1994.
6. Okubo, Y., Suhara, T., Suzuki, K., Kobayashi, K., Inoue, O., Terasaki, O., Someya, Y., Sassa, T., Sudo, Y., Matsushima, E., Iyo, M., Tateno, Y., and Toru, M., Decreased prefrontal dopamine D1 receptors in schizophrenia revealed by PET, Nature, 385, 634, 1997.
7. Dearry, A., Gingrich, J.A., Falardeau, P., Fremeau, R.T., Bates, M.D., and Caron, M.G., Molecular cloning and expression of the gene for a human D1 dopamine receptor, Nature, 347, 72, 1990.
8. Zhou, Q.-Y., Grandy, D.K., Thambi, L., Kushner, J.A., Van Tol, H.H.M., Cone, R., Pribnow, D., Salon, J., Bunzow, J.R., and Civelli, O., Cloning and expression of human and rat D1 dopamine receptors, Nature, 347, 76, 1990.
9. Sunahara, R.K., Niznik, H.B., Weiner, D.M., Stormann, T.M., Brann, D.M., Kennedy, J.L., Gelernter, J.E., Rozmahel, R., Yang, Y., Israel, Y., Seeman, P., and O’Dowd, B.F., Human dopamine D1 receptor encoded by an intronless gene on chromosome 5, Nature, 347, 80, 1990.
10. Sunahara, R.K., Guan, H.-C., O’Dowd, B.F., Seeman, P., Laurier, L.G., Ng, G., George, S.R., Torchia, J., Van Tol, H.H.M., and Niznik, H.B., Cloning of the gene for a human dopamine D5 receptor with higher affinity for dopamine than D1, Nature, 350, 614, 1991.
11. Sherrington, R., Mankoo, B., Attwood, J., Kalsi, G., Curtis, D., Buetow, K., Povey, S., and Gurling, H., Cloning of the human dopamine D5 receptor gene and identification of a highly polymorphic microsatellite for the DRD5 locus that shows tight linkage to the chromosome 4p reference marker RAF1P1, Genomics, 18, 423, 1993.
12. Minowa, M.T., Minowa, T., Monsma, F.J., Sibley, D.R., and Mouradian, M.M., Characterization of the 5' flanking region of the human D1A dopamine receptor gene, Proc. Natl. Acad. Sci. U.S.A., 89, 3045, 1992.
13. Meador-Woodruff, J.H., Damask, S.P., Wong, J., Haroutunian, V., Davis, K.L., and Watson, S.J., Dopamine receptor mRNA expression in human striatum and neocortex, Neuropsychopharmacology, 15, 17, 1996.
14. Meador-Woodruff, J.H., Grandy, D.K., Van Tol, H.H.M., Damask, S.P., Little, K.Y., Civelli, O., and Watson, S.J., Dopamine receptor gene expression in the human medial temporal lobe, Neuropsychopharmacology, 10, 239, 1994.
15. Hall, H., Sedvall, G., Magnuson, O., Kopp, J., Halldin, C., and Farde, L., Distribution of D1-and D2-dopamine receptors, and dopamine and its metabolites in the human brain, Neuropsychopharmacology, 11, 245, 1994.
16. Joyce, J.N., Lexow, N., Bird, E., and Winokur, A., Organization of dopamine D1 and D2 receptors in human striatum: receptor autoradiographic studies in Huntington’s disease and schizophrenia, Synapse, 2, 546, 1988.
17. Knable, M.B., Hyde, T.M., Murray, A.M., Herman, M.M., and Kleinman, J.E., A postmortem study of frontal cortical dopamine D1 receptors in schizophrenics, psychiatric controls, and normal controls, Biol. Psychiatry, 40, 1191, 1996.
18. Yang, C.R. and Seamans, J.K., Dopamine D1 receptor actions in layer V-VI rat prefrontal cortex neurons in vivo: modulation of dendric-somatic signal integration., J. Neurosci., 16, 1922, 1996.
19. Brozoski, T.J., Brown, R.M., Rosvold, H.E., and Goldman, P.S., Cognitive deficit caused by regional depletion of dopamine in prefrontal cortex of rhesus monkey, Science, 205, 929, 1979.
20. Sawaguchi, T. and Goldman, R.P., D1-dopamine receptors in prefrontal cortex: involvement in working memory, Science, 251, 947, 1991.
21. Sawaguchi, T. and Goldman, R.P., The role of D1-dopamine receptor in working memory: local injections of dopamine antagonists into the prefrontal cortex of rhesus monkeys performing an oculomotor delayed-response task, J. Neurophysiol., 71, 515, 1994.
22. Williams, G.V. and Goldman-Rakiv, P.S., Modulation of memory fields by dopamine D1 receptors in prefrontal cortex, Nature, 376, 572, 1995.
23. Murphy, B.L., Arnsten, A.F.T., Goldman-Rakic, P.S., and Roth, R.H., Increased dopamine turnover in the prefrontal cortex impairs spatial working performance in rats and monkeys, Proc. Natl. Acad. Sci. U.S.A., 93, 1325, 1996.
24. Ujike, H., Onoue, T., Akiyama, K., Hamamura, T., and Otsuki, S., Effects of selective D-1 and D-2 dopamine antagonists on development of methamphetamine-induced behavioral sensitization, Psychopharmacology, 98, 89, 1989.
25. Ujike, H., Akiyama, K., Nishikawa, H., Onoue, T., and Otuski, S., Lasting increase in D1 dopamine receptors in the lateral part of the substantia nigra reticulata after subchronic methamphetamine administration, Brain Res., 540, 159, 1991.
26. Vezina, P., D1 dopamine receptor activation is necessary for the induction of sensitization by amphetamine in the ventral tegmental area, J. Neurosci., 16, 2411, 1996.
27. Mashurano, M. and Waddington, J.L., Stereotyped behaviour in response to the selective D-2 dopamine receptor agonist RU 24213 is enhanced by pretreatment with the selective D-1 agonist SK&F 38393, Neuropharamcology, 25, 947, 1986.
28. Walter, J.R., Bergstrom, D.A., Carlson, J.H., Chase, T.N., and Braun, A.R., D1 dopamine receptor activation required for postsynaptic expression of D2 agonist effects, Science, 236, 719, 1987.
29. +) ATPase activity in neostriatal neurons through D1 and D2 dopamine receptor synergism, Nature, 347, 386, 1990.
30. Piomelli, D., Pilon, C., Giros, B., Sokoloff, P., Martes, M.-P., and Schwartz, J.-C., Dopamine activation of the arachidonic acid cascade as a basis for D1/D2 receptor synergism, Nature, 353, 164, 1991.
31. LaHoste, G.J., Yu, J., and Marshall, J.F., Striatal Fos expression is indicative of dopamine D1/D2 synergism and receptor supersensitivity, Proc. Natl. Acad. Sci. U.S.A., 90, 7451, 1993a.
32. Ruskin, D.N. and Marshall, J.F., D1 dopamine receptors influence Fos immunoreactivity in the globus pallidus and subthalamic nucleus of intact and nigrostriatal-lesioned rats, Brain Res., 703, 156, 1995.
33. Robertson, G.S. and Robertson, H.A., Synergistic effects of D1 and D2 dopamine agonists on turning behavior in rats, Brain Res., 384, 387, 1986.
34. Calabresi, P., Maj, R., Pisani, A., Mercuri, N.B., and Bernard, G., Long-term synaptic depression in the striatum: physiological and phramacological characterization, J. Neurosci., 12, 4224, 1992.
35. Paul, M.L., Graybiel, A.M., David, J.-C., and Robertson, H.A., D1-like and D2-like dopamine receptors synergistically activate rotation and c-fos expression in the dopamine-depleted striatum in a rat model of Parkinson’s disease, J. Neurosci., 12, 3729, 1992.
36. Keefe, K.A. and Gerfen, C.R., D1-D2 dopamine receptor synergy in striatum: effects of intrastrial infusion of dopamine agonists and antagonists on immediate early gene expression, Neuroscience, 66, 903, 1995.
37. Kashihara, K., Akiyama, K., Ishihara, T., Shiro, Y., and Shohmori, T., Synergistic effects of D1 and D2 dopmaine receptors on AP-1 DNA-binding activity in the striatum and globus pallidus of the rat with a unilateral 6-OHDA lesion of the medial forebrain bundle, Life Sci., 59, 1683, 1996.
38. LaHoste, G.J. and Marshall, J.F., The role of dopamine in the maintenance and breakdown of D1/D2 synergism, Brain Res., 611, 108, 1993b.
39. Hu, X.-T., Wachtel, S.R., Galloway, M.P., and White, F.J., Lesions of nigrostriatal dopamine projection increase the inhibitory effects of D1 and D2 dopamine agonists on caudate-putamen neurons and relieve D2 receptors from the necessity of D1 receptor stimulation, J. Neurosci., 10, 2318, 1990.
40. Gerfen, C.H., Engber, T.M., Mahan, L.C., Susel, Z., Chase, T.N., Monsma, F.J.J., and Sibley, D.R., D1 and D2 dopamine receptor-regulated gene expression of striatonigral and striatopallidal neurons, Science, 250, 1429, 1990.
41. Carlsson, M. and Carlsson, A., Schizophrenia: a subcortical neurotransmitter imbalance syndrome?, Schizophr. Bull., 16, 425, 1990.
42. Weinberger, D.R., Berman, K.F., and Zec, R.F., Physiologic dysfunction of dorsolateral prefrontal cortex in schizophrenia. I. Regional cerebral blood flow evidence, Arch. Gen. Psychiatry, 43, 114, 1986.
43. Cichon, S., Nöhen, M.M., Stöer, G., Schroers, R., Albus, M., Maier, W., Rietschel, M., Köner, J., Weigelt, B., Franzek, E., Wildenauer, D., Fimmers, R., and Propping, P., Systematic screening for mutations in the 5'-regulatory region of the human dopamine D1 receptor (DRD1) gene in patients with schizophrenia and bipolar affective disorder, Am. J. Med. Genet., 67, 424, 1996.
44. Cichon, S., Nöhen, M.M., Rietschel, M., Köner, J., and Propping, P., Single-strand conformation analysis (SSCA) of the dopamine D1 receptor gene (DRD1) reveals no significant mutation in patients with schizophrenia and manic depression, Biol. Psychiatry, 36, 850, 1994.
45. Ohara, K., Ulpian, C., Seeman, P., Sunahara, R.K., Van, T.H., and Niznik, H.B., Schizophrenia: dopamine D1 receptor sequence is normal, but has DNA polymorphisms, Neuropsychopharmacology, 8, 131, 1993.
46. Liu, Q., Sobell, J.L., Heston, L.L., and Sommer, S.S., Screening the dopamine D1 receptor gene in 131 schizophrenics and eight alcoholics: identification of polymorphisms but lack of functionally significant sequence changes, Am. J. Med. Genet., 60, 165, 1995.
47. Sobell, J., Lind, T.J., Sigurdson, D.C., Zald, D.H., Snitz, B.E., Grove, W.M., Heston, L.L., and Sommer, S.S., The D5 dopamine receptor gene in schizophrenia: identification of a nonsense change and multiple missense changes but lack of association with disease, Hum. Mol. Genet., 4, 507, 1995.
48. Feng, J., Sobell, J.L., Heston, L.L., Cook, E.J., Goldman, D., and Sommer, S.S., Scanning of the dopamine D1 and D5 receptor genes by REF in neuropsychiatric patients reveals a novel missense change at a highly conserved amino acid, Am. J. Med. Genet., 81, 172, 1998.
49. Jensen, S., Plaetke, R., Holik, J., Hoff, M., Myles, W.M., Leppert, M., Coon, H., Vest, K., Freedman, R., and Waldo, M., Linkage analysis of schizophrenia: the D1 dopamine receptor gene and several flanking DNA markers, Hum. Hered., 43, 58, 1993.
50. Coon, H., Byerley, W., Holik, J., Myles-Worsley, M., Lannfelt, L., Sokoloff, P., Schwartz, J.-C., Waldo, M., Freedman, R., and Plaetke, R., Linkage analysis of schizophrenia with five dopamine receptor genes in nine pedigrees, Am. J. Hum. Genet., 52, 327, 1993.
51. Campion, D., d’Amato, T., Bastard, C., Laurent, C., Guedj, F., Jay, M., Dollfus, S., Thibaut, F., Petit, M., and Gorwood, P., Genetic study of dopamine D1, D2, and D4 receptors in schizophrenia, Psychiatry Res., 51, 215, 1994.
52. Nöhen, M.M., Köner, J., Lannfelt, L., Sokoloff, P., Schwartz, J.-C., Lanczik, M., Rietschel, M., Cichon, S., Kramer, R., Fimmers, R., Möler, H.-J., Beckmann, H., Propping, P., Grandy, D.K., Civelli, O., and O’Dowd, B., Lack of association between schizophrenia and alleles of the dopamine dopamine D1, D2, D3 and D4 receptor loci, Psychiatr. Genet., 3, 89, 1993.
53. Kojima, H., Ohmori, O., Shinkai, T., Terao, T., Suzuki, T., and Abe, K., Dopamine D1 receptor gene polymorphism and schizophrenia in Japan, Am. J. Med. Genet., 88, 116, 1999.
54. Kalsi, G., Sherrington, R., Mankoo, B.S., Brynjolfsson, J., Sigmundsson, T., Curtis, D., Read, T., Murphy, P., Butler, R., Petursson, H., and Gurling, H.M., Linkage study of the D5 dopamine receptor gene (DRD5) in multiplex Icelandic and English schizophrenia pedigrees, Am. J. Psychiatry, 153, 107, 1996.
55. Carenzi, A., Gillin, J., Guidotti, A., Schwartz, M.A., Trabucchi, M., and Wyatt, R.J., Dopaminesensitive adenylyl cyclase in human caudate nucleus, Arch. Gen. Psychiatry, 32, 1056, 1975.
56. Memo, M., Kleinman, J.E., and Hanbauer, I., Coupling of dopamine D1 recognition sites with adenylate cyclase in nuclei accumbens and caudatus of schizophrenics, Science, 221, 1304, 1983.
57. Cross, A.J., Crow, T.J., and Owen, F., 3H-flupenthixol binding in post-mortem brains of schizophrenics: evidence for aselective increase in dopamine D2 receptors, Psychopharmacology, 74, 122, 1981.
58. Pimoule, C., Schoemaker, H., Reynolds, G.P., and Langer, S.Z., [3H]SCH 23390 labeled D1 dopamine receptors are unchanged in schizophrenia and Parkinson’s disease, Eur. J. Pharmacol., 114, 235, 1985.
59. Hess, E.J., Bracha, H.S., Kleinman, J.E., and Creese, I., Dopamine receptor subtype imbalance in schizophrenia, Life Sci., 40, 1487, 1987.
60. Mamelok, M., Chiu, S., and Mishra, R.K., High-and low-affinity states of dopamine D1 receptors in schizophrenia, Eur. J. Pharmacol, 233, 175, 1993.
61. Knable, M.B., Hyde, T.M., Herman, M.M., Carter, J.M., Bigelow, L., and Kleinman, J.E., Quantitative autoradiography of dopamine-D1 receptors, D2 receptors, and dopamine uptake sites in postmortem striatal specimens from schizophrenic patients, Biol. Psychiatry, 36, 827, 1994.
62. Domyo, T., Kurumaji, A., Yoshikawa, T., and Toru, M., Increased dopamine D1 receptors in cerebral cortex of schizophrenics: a postmortem study, in 28th Ann. Meet. Soc. Neuroscience, Abstracts (Part 1), 988, 1998.
63. Dean, B., Hussain, T., Hayes, W., Scarr, E., Kitsoulis, S., Hill, C., Opeskin, K., and Copolov, D.L., Changes in serotonin 2A and GABAA receptors in schizophrenia: studies on the human dorsolateral prefrontal cortex, J. Neurochem., 72, 1593, 1999.
64. Harrington, K.A., Augood, S.J., Faull, R.L., McKenna, P.J., and Emson, P.C., Dopamine D1 receptor, D2 receptor, proenkephalin A and substance P gene expression in the caudate nucleus of control and schizophrenic tissue: a quantitative cellular in situ hybridisation study, Brain Res. Mol. Brain Res., 33, 333, 1995.
65. Meador-Woodruff, J.H., Haroutunian, V., Powchik, P., Davidson, M., Davis, K.L., and Watson, S.J., Dopamine receptor transcript expression in striatum and prefrontal and occipital cortex: focal abnormalities in orbitofrontal cortex in schizophrenia, Arch. Gen. Psychiatry, 54, 1089, 1997.
66. Karlsson, P., Falde, L., Halldin, C., Nordstorm, A.-L., and Sedvall, G., D1-dopamine receptor binding in drug naive schizophrenic patients measured by PET, Psychopharmacology, 13 (Suppl. 1), S556, 1993.
67. Sedvall, G. and Farde, L., Chemical brain anatomy in schizophrenia, Lancet, 346, 743, 1995.
68. Suhara, T., Nakayama, K., Inoue, O., Fukuda, H., Shimuzu, M., Mori, A., and Tateno, Y., D1 dopamine receptor binding in mood disorders measured by positron emission tomography, Psychopharmacology, 106, 14, 1992.
69. Sedvall, G., Karlsson, P., Lundin, A., Anvret, M., Suhara, T., Halldin, C., and Farde, L., Dopamine D1 receptor number - a sensitive PET marker for early brain degeneration in Huntington’s disease, Eur. Arch. Psychiatry Clin. Neurosci., 243, 249, 1994.
70. Brown, A. and Gershon, S., Dopamine and depression, J. Neural Transm. Gen. Sect., 91, 75, 1993.
71. D’Aquila, P.S., Collu, M., Pani, L., Gessa, G.L., and Serra, G., Antidepressant-like effect of selective dopamine D1 receptor agonists in the behavioural despair animal model of depression, Eur. J. Pharmacol., 262, 107, 1994.
72. Karlsson, P., Smith, L., Farde, L., Haernryd, C., Sedvall, G., and Wiesel, F.A., Lack of apparent antipsychotic effect of the D1-dopamine receptor antagonist in acutely ill schizophrenic patients, Psychopharmacology, 121, 309, 1995.
73. Den Boer, J.A., van Megen, H.J.G.M., Fleischhacker, W.W., Louwerens, J.W., Slaap, B.R., Westenberg, H.G., Burrows, G.D., and Srivastava, O.N., Differential effects of the D1-DA receptor antagonist SCH39166 on positive and negative symptoms of schizophrenia, Psychopharmacology, 121, 317, 1995.
74. De Beaurepaire, R., Labelle, A., Naber, D., Jones, B.D., and Barnes, T.R., An open trial of the D1 antagonist SCH 39166 in six cases of acute psychotic states, Psychopharmacology, 121, 323, 1995.
75. Karle, J., Clemmesen, L., Hansen, L., Andersen, M., Andersen, J., Fensbo, C., Sloth, N.M., Skrumsager, B.K., Lublin, H., and Gerlach, J., NNC 01-0687, a selective dopamine D1 receptor antagonist, in the treatment of schizophrenia, Psychopharmacology, 121, 328, 1995.
76. Barnes, T.R. and Gerlach, J., D1 receptor antagonists in schizophrenia, Psychopharmacology, 121, 287, 1995.
77. Davidson, M., Harvey, P.D., Bergman, R.L., Powchik, P., Kaminsky, R., Losonczy, M.F., and Davis, K.L., Effects of the D-1 agonist SKF-38393 combined with haloperidol in schizophrenic patients, Arch. Gen. Psychiatry, 47, 190, 1990.
78. Lidow, M.S. and Goldman, R.P., A common action of clozapine, haloperidol, and remoxipride on D1-and D2-dopaminergic receptors in the primate cerebral cortex, Proc. Natl. Acad. Sci. U.S.A., 91, 4353, 1994.
79. Lidow, M.S., Elsworth, J.D., and Goldman, R.P., Down-regulation of the D1 and D5 dopamine receptors in the primate prefrontal cortex by chronic treatment with antipsychotic drugs, J. Pharmacol. Exp. Ther., 281, 597, 1997.
80. Lidow, M.S., Williams, G.V., and Goldman-Rakic, P.S., The cerebral cortex: a case for a common site of action of antipsychotics, Trends Pharmacol. Sci., 19, 136, 1998.
81. 11C]raclopride, Arch. Gen. Psychiatry, 47, 213, 1990.
82. 11C]N-methylspiperone, Psychiatr. Res. Neuroimaging, 61, 67, 1995.
83. Hietala, J., Syvalahti, E., Vuorio, K., Nagren, K., Lehikoinen, P., Ruotsalainen, U., Rakkolainen, V., Lehtinen, V., and Wegelius, U., Striatal D2 dopamine receptor characteristics in neuroleptic-naive schizophrenic patients studied with positron emission tomography, Arch. Gen. Psychiatry, 51, 116, 1994.
84. 76Br]bromospiperone in untreated schizophrenia, Am. J. Psychiatry, 147, 44, 1990.
85. 18F]setoperone in neurolepticnaive patients and normal subjects, Am. J. Psychiatry, 156, 72, 1999.
86. Trichard, C., Paillere, M.M., Attar, L.D., Blin, J., Feline, A., and Martinot, J.L., No serotonin 5-HT2A receptor density abnormality in the cortex of schizophrenic patients studied with PET, Schizophr. Res., 31, 13, 1998.
87. Suhara, T., Fukuda, H., Inoue, O., Itoh, T., Suzuki, K., Yamasaki, T., and Tateno, Y., Age-related changes in human D1 dopamine receptors measured by positron emission tomography, Psychopharmacology, 103, 41, 1991.